Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

56
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
56
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

44
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
44
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

75
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
75
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

87
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
87
Prediction Intervals01:03

Prediction Intervals

2.2K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
2.2K
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

3.0K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gastrointestinal Motility-Induced Interplay in Pancreas Proton Therapy: Motion Simulation and Dosimetric Impact.

International journal of radiation oncology, biology, physics·2026
Same author

A transgenic rotifer-based RNA interference approach for antiviral protection against <i>Covert mortality nodavirus</i> in shrimp aquaculture.

Frontiers in microbiology·2026
Same author

An integrative framework combining Mendelian randomization, single-cell profiling, and experimental validation identifies FTMT as a mitochondrial-immune regulator in non-small cell lung cancer.

Cancer cell international·2026
Same author

Intratumoral bicarbonate functions as an adjuvant to potentiate PD-1 blockade in hepatocellular carcinoma.

Oncogene·2026
Same author

Pediatric Liver Transplantation: A Single-Center Retrospective Study.

Pediatric transplantation·2026
Same author

Design and implementation of an AAPM volunteer database for advancing global medical physics initiatives.

Journal of applied clinical medical physics·2026

Related Experiment Video

Updated: Jun 5, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Federated learning for enhanced dose-volume parameter prediction with decentralized data.

Jiahan Zhang1, Yang Lei1, Junyi Xia1

  • 1Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Medical Physics
|December 6, 2024
PubMed
Summary
This summary is machine-generated.

Federated learning (FL) enables accurate radiation oncology planning by training a central model with distributed, private data. This approach matches centralized model performance without data sharing, overcoming adoption barriers.

Keywords:
federated learningknowledge‐based planningmachine learningtreatment planning

More Related Videos

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

502
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K

Related Experiment Videos

Last Updated: Jun 5, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

502
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K

Area of Science:

  • Radiation Oncology
  • Machine Learning
  • Medical Data Privacy

Background:

  • Knowledge-based planning in radiation oncology is limited by data scarcity and challenges in sharing medical data.
  • These limitations hinder the widespread adoption of advanced planning techniques.

Purpose of the Study:

  • To assess the feasibility of federated learning (FL) to overcome data sharing limitations in radiation oncology.
  • To develop a privacy-preserving method for training a centralized model using distributed datasets.

Main Methods:

  • A gradient-boosting model predicted bladder and rectum dose-volume metrics (V30Gy, V35Gy, V40Gy) using 273 prostate cancer plans.
  • The Federated Averaging algorithm aggregated model weights from 10 simulated clinic subsets.
  • Model robustness was tested with varying numbers of sites and imbalanced data distributions.

Main Results:

  • The FL model achieved a mean absolute error (MAE) of 4.7% ± 2.9%, significantly lower than individual models (6.5% ± 4.9%) and comparable to a centralized model (4.4% ± 2.8%).
  • The FL model demonstrated robustness across different numbers of subsets (5-30) and performed well on imbalanced datasets.
  • The FL approach outperformed 36.7% of individual models for bladder and rectum metrics.

Conclusions:

  • Federated learning offers a viable solution for knowledge-based planning in radiation oncology, enhancing prediction accuracy without centralizing sensitive patient data.
  • FL models maintain high performance even with data scarcity at local sites, proving more robust than individually trained models.